Welcome to IPCOR, the Irish Prostate Cancer Outcomes Research

IPCOR is collecting clinical data and quality of life information from men who have been newly diagnosed with prostate cancer in Ireland and is developing, for the first time, a national prostate cancer registry. IPCOR publishes annual reports on the outcomes of prostate cancer treatment and care. These reports provide evidence-based data to doctors, hospitals and policy makers to inform future healthcare decisions that affect prostate cancer care.

The ultimate goal of IPCOR is to enhance prostate cancer care, improve patient experiences and maximise quality of life for men diagnosed with prostate cancer in Ireland.

The Irish Prostate Cancer Outcomes Research began in February 2014. The Irish Cancer Society and Movember are supporting this project with funding of €1.75 million over 5 years. This research is being carried out by a collaborative partnership involving the National Cancer Registry Ireland, the HRB Clinical Research Facility in Galway, the National Cancer Control Program and the nation’s major academic institutions represented by Clinical Research Development Ireland.


Latest News

IPCOR APP: patientMpower

To find out more see here

IPCOR APP: <i>patientMpower</i>

IPCOR FAQs

To find out more see here

IPCOR FAQs

IPCOR Annual Report 2018

 

 IPCOR Annual Report 2018

IPCOR Annual Report
2018

Executive Summary

IPCOR Annual Report<br> 2018

Interested in improving prostate cancer care?

Join IPCOR’s patient panel.

Interested in improving prostate cancer care?
To find out more contact emma@ipcor.ie

IPCOR is developing a Registry of men who have been newly diagnosed with Prostate Cancer in Ireland

Read More

Partners

 

Funders